Oxylanthanum Carbonate
UNI-OLC-201
Phase 2 small_molecule completed
Quick answer
Oxylanthanum Carbonate for Chronic Kidney Disease Requiring Chronic Dialysis is a Phase 2 program (small_molecule) at Unicycive Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Unicycive Therapeutics
- Indication
- Chronic Kidney Disease Requiring Chronic Dialysis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed